Firefly Neuroscience, Inc. (AIFF)

Firefly Neuroscience, Inc. (AIFF) — VMCI valuation read

Firefly Neuroscience, Inc. (AIFF) carries a VMCI composite of 31/100, 19 points below the Technology sector median of 50. Among mid-cap names, that gap places AIFF in the bottom third on the five-pillar weighting (Value 35%, Quality 30%, Integrity 15%, Growth 12%, Risk 8%).

The AIFF insider tape has been silent for the past 30 days on Form 4. Where executives neither buy nor sell, the bull and bear cases lean harder on filings cadence and the next earnings line.

**Investor frame.** Value reads AIFF trades at 16.0x earnings, 11% below the Technology median of 18.0x, which compresses or extends through the 11.0x EV/EBITDA versus a Technology 12.0x. Quality: ROIC of 14.0% sits 4.0pp above the Technology median (10.0%). Risk: net debt to EBITDA of 2.5x is the rate-sensitivity line to watch, the line to track on Firefly Neuroscience, Inc.'s next 10-Q.

AIFF rose 3.2% over the trailing 7 days, with a -21.0% read on a 30-day basis.